Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis.
Cognitive behavior therapy
Family intervention
Omega-3 fatty acid
Prevention
Psychosis
Ultra-high risk
Journal
Clinical psychology review
ISSN: 1873-7811
Titre abrégé: Clin Psychol Rev
Pays: United States
ID NLM: 8111117
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
08
07
2020
revised:
14
01
2021
accepted:
01
03
2021
pubmed:
4
4
2021
medline:
26
10
2021
entrez:
3
4
2021
Statut:
ppublish
Résumé
Intervention at the earliest illness stage, in ultra or clinical high-risk individuals, or indicated prevention, currently represents the most promising strategy to ameliorate, delay or prevent psychosis. We review the current state of evidence and conduct a broad-spectrum meta-analysis of various outcomes: transition to psychosis, attenuated positive and negative psychotic symptoms, mania, depression, anxiety, general psychopathology, symptom-related distress, functioning, quality of life, and treatment acceptability. 26 randomized controlled trials were included. Meta-analytically pooled interventions reduced transition rate (risk ratio [RR] = 0.57, 95%CI 0.41-0.81) and attenuated positive psychotic symptoms at 12-months (standardized mean difference = -0.15, 95%CI = -0.28--0.01). When stratified by intervention type (pharmacological, psychological), only the pooled effect of psychological interventions on transition rate was significant. Cognitive behavioral therapy (CBT) was associated with a reduction in incidence at 12-months (RR = 0.52, 95%CI = 0.33-0.82) and 18-48-months (RR = 0.60, 95%CI = 0.42-0.84), but not 6-months. Findings at 12-months and 18-48-months were robust in sensitivity and subgroup analyses. All other outcomes were non-significant. To date, effects of trialed treatments are specific to transition and, a lesser extent, attenuated positive symptoms, highlighting the future need to target other symptom domains and functional outcomes. Sound evidence supports CBT in reducing transition and the value of intervening at this illness stage. STUDY REGISTRATION: Research Registry ID: reviewregistry907.
Identifiants
pubmed: 33810885
pii: S0272-7358(21)00048-9
doi: 10.1016/j.cpr.2021.102005
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102005Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.